Yi‐Jun Wang - Concepedia

Author

Yi‐Jun Wang

St. John's University ORCID

Also Known As

Herrera G, Julius NIYIBIZI, N Restifo, Wang Y, Wang, Yijun, Y Wang, YI-JUN WANG, Yi-Jun Wang, Yi-jun Wang, Yijun Wang

124

Publications

3.2K

Citations

H-Index

Concepts

All Affiliations

St. John's University Center for Cancer Research National Cancer Institute Sun Yat-sen University National Institutes of Health

About

Yi‐Jun Wang is an author at St. John's University specializing in medicine, pharmacology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	22	1.1K
2	Biochemistry	8	8	433
3	Natural Sciences	7	7	411
4	Health Sciences	3	3	136
5	Engineering	2	2	116

Yi‐Jun Wang

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients Geok Choo Sim, Natalia Martín‐Orozco, Lei Jin, Journal of Clinical Investigation	2013	224
The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Michael Reed, Birgit Woelker, P Wang, Proceedings of the National Academy of Sciences Dna DamageRadiation EffectRadiation ExposureMolecular BiologyCell Death	1995	188
Costimulation Through the CD137/4-1BB Pathway Protects Human Melanoma Tumor-infiltrating Lymphocytes From Activation-induced Cell Death and Enhances Antitumor Effector Function Jessica Ann Hernandez-Chacon, Yufeng Li, Richard C. Wu, Journal of Immunotherapy ImmunologyImmunoeditingImmune Cell TherapyImmunotherapyTumor Biology	2011	134
Melanoma Cells Express ICOS Ligand to Promote the Activation and Expansion of T-Regulatory Cells Natalia Martín‐Orozco, Yufeng Li, Yi‐Jun Wang, Cancer Research	2010	132
Tumor-Infiltrating FoxP3+ Tregs and CD8+ T Cells Affect the Prognosis of Hepatocellular Carcinoma Patients Yong Huang, Fengmei Wang, Tao Wang, Digestion	2012	100
Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy Liwei Jiang, Yi‐Jun Wang, Jing Zhao, Cell ImmunologyTumor ImmunityDirect Tumor KillingImmune Checkpoint InhibitorCancer Treatment	2020	94
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells Pranav Gupta, Yunkai Zhang, Xiaoyu Zhang, Cellular Physiology and Biochemistry	2018	81
Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: In vitro and in vivo study Yi‐Jun Wang, Yunkai Zhang, Guan-Nan Zhang, Cancer Letters Health SciencesMedicinePharmacologyColorectal CancerAbcb1 Transporter	2017	80
Recent Advances in Direct Functionalization of Quinones Yi‐Jun Wang, Shuai Zhu, Liang‐Hua Zou European Journal of Organic Chemistry Diversity Oriented SynthesisCross-coupling ReactionBioorganic ChemistryDerivativesEngineering	2019	67
CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3 Weibo Feng, Wenjie Huang, Jie Chen, Theranostics Cxcl12-mediated Hoxb5 OverexpressionCrc MetastasisMedicineColorectal CancerPathology	2021	64

Page 1